1. Wiesenfeld D, Ferguson MM, Mitchell DN, MacDonald DG, Scully C, Cochran K, et al. Oro-facial granulomatosis – A clinical and pathological analysis. Q J Med. 1985 Jan;54(213):101-13. 2. Challacombe SJ. Oro-facial granulomatosis and oral crohns disease: Are they specific dis-eases and do they predict systemic Crohns dis-ease? Oral Dis. 1997 Sep;3(3):127-9. 3. Alioğlu Z, Caylan R, Adanir M, Ozmenoğlu M..Melkersson-Rosenthal syndrome: report of three cases. Neurol Sci. 2000 Feb;21(1):57-60. 4. Rosenthal C.Klinisch-erbbiologischer Beitrag zur Kon- stitutions-Patologie: Gemeinsames Aiftreten von (rezidivie- render familiarer) Fazialislahmung, angineurotschem Gesichtsodem und Lingua plicata in Arthris-musfamilien. Ztschr Neurol Psych 1931; 131:475–501. 5. Kuske H. Macrocheilia granulomatosa with recurrent right facial nerve paralysis (Melkers-son-Rosenthal synd.); cheilitis granulomatosa; macrocheilia with chronic recurrent erysipelas of the upper lip. Dermatologica. 1955 Mar-May; 110 (3-5):392-6. 6. Shengold MA, Sheingold H.Oral tuberculo-sis.Oral Surg Oral Med Oral Pathol. 1951 Feb;4 (2):239 .50. 7. Crohn BB, Ginsburg L, Oppenheimer GD. Regional ileitis 1932: A pathologic and clinical entity. Mt Sinai J Med. 2000 May;67(3):263-8. 8. Sanderson J, Nunes C, Escudier M,et al. Oro-facial granulomatosis: Crohn's disease or a new inflammatory bowel disease? Inflamm Bowel Dis. 2005 Sep;11(9):840-6. 9. Mignogna MD, Fedele S, Lo RL, Lo ML. The multiform and variable patterns of onset of oro-facial granulomatosis J Oral Pathol Med. 2003 Apr;32(4):200-5. 10. Odukoya O. Orofacial granulomatosis: re-port of two Nigerian cases. J Trop Med Hyg. 1994 Dec; 97(6):362-6. 11. Rogers RS III. Melkersson-Rosenthal syn-drome and orofacial granulomatosis. Dermatol Clin. 1996 Apr;14(2):371-9. 12. Sainsbury CP, Dodge JA, Walker DM, Al-dred MJ. Orofacial granulomatosis in child-hood. Br Dent J. 1987 Sep 5; 163(5):154-7. 13. Clayden AM, Bleys CM, Jones SF, Savage NW, Aldred MJ. Orofacial granulomatosis: A diagnostic problem for the unw-ary and a man-agement dilemma. Aust Dent J. 1997 Aug; 42(4):228-32. 14. Eveson JW. Granulomatous disorders of the oral mucosa. Semin Diagn Pathol. 1996 May; 13 (2):118-27. 15. Leão JC, Hodgson T, Scully C, Porter S. Review article: orofacial granulomatosis. Aliment Pharmacol Ther. 2004 Nov 15;20(10):1019-27 16. Daley T, Armstrong J. Oral manifestations of gastrointestinal diseases. Can J Gastroenterol. 2007 Apr;21(4):241-4. 17. Sciubba JJ, Said-AI-Naief N. Orofacial granulomatosis: Presentation, pathology and management of 13 casesJ Oral Pathol Med. 2003 Nov; 32(10):576-85. 18. Nevil B, Damm D, Allen C, Bouquot J.Oral and Maxillofacial Pathology. 3rd. ed. Philaadel-phia: W.B. Saunders; 2009;341-345. 19. Mignogna MD, Fedele S, Lo RL, Lo ML. Orofacial granulo-matosis with gingival onset. J Clin Periodontol. 2001 Jul;28(7):692-6. 20. Gottwald W. Melkersson-Rosenthal syn-drome: 2. Diagnosis, differential diagnosis, course, prognosis, neuropathology, therapy. Fortschr Med. 1981 Mar 12;99(10):326-30. 21. James J, Ferguson MM.Orofacial granulomatosis presenting clinically as tuberculosis of cervical lymph nodes. Br Dent J. 1986 Jul 5; 161(1):17-9. 22. Loftus EV Jr. Clinical epidemiology of in-flammatory bowel disease: incidence, preva-lence, and environmental influences. Gastroen-terology. 2004 May;126(6):1504-17. 23. Oliver AJ, Rich AM, Reade PC, Varigos GA, Radden BG. Monosodium glutamate-related orofacial granulomatosis. Review and case re-port. Oral Surg Oral Med Oral Pathol. 1991 May; 71 (5):560-4. 24. Taibjee SM, Prais L, Foulds IS. Orofacial granulomatosis worsened by chocolate: results of patch testing to ingredients of Cadbury’s chocolate. Br J Dermatol. 2004 Mar;150(3):595. 25. Lazarov A, Kidron D, Tulchinsky Z, Min-kow B. Contact orofacial granulomatosis caused by delayed hypersensitivity to gold and mercu-ry. J Am Acad Dermatol. 2003 Dec;49(6):1117-20. 26. Guttman-Yassky E, Weltfriend S, Bergman R. Resolution of orofacial granulomatosis with amalgam removal. J Eur Acad Dermatol Vene-reol. 2003 May;17(3):344-7. 27. Riggio MP, Gibson J, Lennon A, Wray D, MacDonald DG. Search for Mycobacterium paratuberculosis DNA in orofacial granulo-matosis and oral Crohn’s disease tissue by pol-ymerase chain reaction. Gut. 1997 Nov; 41(5):646-50. 28. Meisel-Stosiek M, Hornstein OP, Stosiek N.Family study on Melkersson-Rosenthal syn-drome. Some hereditary aspects of the disease and review of literature.Acta Derm Venereol. 1990; 70 (3):221-6. 29. Van der Waal RIF, Schulten EAJM, Van de Scheur MR, et al.Cheilitis granulomatosa.J Eur Acad Dermatol Venereol. 2001 Nov;15(6):519-23. 30. Satsangi J, Jewell DP, Rosenberg WMC, Bell JI. Genetics of inflammatory bowel disease. Gut. 1994 May; 35(5):696-700. 31. Gibson J, Wray D. Human leucocyte antigen typing in` orofacial granulomatosis. Br J Derma-tol. 2000 Nov; 143(5):1119-21. 32. James J, Patton DW, Lews CJ, Kirkwood MM, Ferguson MM.Orofacial granulomatosis and clinical atopy. J Oral Med. 1986 Jan-Mar; 41 (1):29-30. 33. Armstrong DK, Biagioni P, Lamey PJ, Bur-rows D. Contact hypersensitivity in patients with orofacial gra- nulomatosis. Am J Contact Dermat. 1997 Mar;8(1):35-8. 34. Sweatman MC, Tasker R, Warner JO, Fergu-son MM, MitchelDN. Orofacialgranulomatosis. Response to elemental diet and provocation by food additives. Clin Allergy. 1986 Jul;16(4):331-8. 35. Sciubba J, Said - Al - Naief N.Orofacial granu-lomatosis: Presentation, pathology and man-agement of 13 cases. J Oral Pathol Med. 2003 Nov;32(10):576-85. 36. Patton DW, Fergusion MM, Forsyth A, James J.Orofa- cial granulomatosis; a possible allergic bias. Br J Oral Maxillofac Surg. 1985 Aug; 23(4): 235-42. 37. Levy FS, Bircher AJ, Buchner SA. Delayed-type hyper-sensitivity to cow’s milk protein in Melkersson-Rosenthal syndrome: Coincidence or pathogenic role? Dermatology 1996;192(2):99-102. 38. Pryce DW, King CM. Orofacial granulo-matosis associated with delayed hypersensitivity to cobalt. Clin Exp Dermatol. 1990 Sep;15(5):384-6. 39. Gibson J, Wray D, Bagg J. Oral staphylo-coccal mucositis: A new clinical entity in orofa-cial granulomatosis and Crohn's disease. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2000 Feb;89(2):171-6. 40. Apaydin R, Bahadir S, Kakklikkaya N, Bi-len N, Bay- ramguler D. Possible role of Myco-bacterium tuberculosis complex in Melkersson Rosenthal syndrome demonstrated with Gen-probe ampli.ed Mycobacterium tuberculosis direct test. Australas J Dermatol. 2004 May; 45(2):94-9. 41. Ivanyl L, Kirby A, Zakrzewska JM. Anti-bodies to Mycobacterial stress protein in pa-tients with orofacial granulomatosis. J Oral Pathol Med. 1993 Aug;22(7):320-2. 42. Savage NW, Barnard K, Shirlaw PJ, Rahman D, Mistry M, Escudier MP, et al. Serum and sal-ivary IgA antibody responses to Saccharomyces cerevisiae, Candida albicans and Streptococcus mutans in orofacial granulomatosis and Crohn's disease. Clin Exp Immunol. 2004 Mar;135(3):483-9. 43. Muellegger RR,Weger W, Zoechling N, et al. Granulo-matous cheilitis and Borrelia burgdor-feri: polymerase chain reaction and serologic studies in a retrospective case series of 12 pa-tients. Arch Dermatol. 2000 Dec; 136(12):1502-6. 44. Liu HG. Spirochetes in the cheilitis granu-lomatosa and sarcoidosis. Zhonghua Yi Xue Za Zhi.1993Mar;73(3):142-4,189-90. 45. Liu HG, Zheng LF, Xiao XZ. Relationship between Melkersson-Rosenthal syndrome and Spirochetes infection. Zhonghua Yi Xue Za Zhi. 1994 Feb;74(2):92-3, 127. 46. Liu H, Zheng L, Liu H. Spirochetes. The possible etiological factor of the cheilitis granu-lomatosa. Chin Med Sci J. 2001 Mar; 16(1): 52-5. 47. Freysdottir J, Zhang S, Tilakaratne WM, For-tune F. Oral biopsies from patients with orofa-cial granulomatosis with histology resembling Crohn’s disease have a prominent Th1 envi-ronment. Inflamm Bowel Dis. 2007 Apr; 1(4):439-45. 48. Facchetti F, Signorini S, Majorana A, Mangannoni MA, Sapelli P, Imberti L. Non-specific influx of T-cell receptor alpha/beta and gamma/delta lymphocytes in mucosal biopsies from a patient with orofacial granulomatosis. J Oral Pathol Med. 2000 Nov;29(10):519-22. 49. Bishop RP, Brewster AC, Antonioli DA. Crohn’s disease of the mouth. Gastroenterolo-gy. 1972 Feb;62(2):302-6. 50. Li MC, Chou G, Chen JT, Wong YK, Ho WL. Amyloidosis of medium-sized arteries pre-senting as perioral mass: a case report. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2003 Apr; 95(4): 463-6. 51. Fujimura T, Aiba S, Suetake T, Tagami H. Erythematous swelling of the lip associated with Sjogren’s syndrome and mimicking cheilitis granulomatosa. J Dermatol. 2001 Jan;28(1):47-9. 52. Hodgson TA, Haricharan AK, Barrett AW, Porter SR. Microcystic adnexal carcinoma: an unusual cause of swell-ing and paraesthesia of the lower lip. Oral Oncol. 2003 Feb;39(2):195-8. 53. High CL, Houston GD. Recurring anterior facial swelling. Compend Contin Educ Dent. 2001 Dec;22(12):1066-8, 1070, 1072. 54. Takada K, Ina Y, Noda M, Sato T, Yama-moto M, Morishita M. The clinical course and prognosis of patients with severe, moderate or mild sarcoidosis. J Clin Epidemiol. 1993 Apr; 46(4): 359-66. 55. Krysl J, Korzeniewska-Kosela M, Muller NL, FitzGerald JM. Radiologic features of pul-monary tuberculosis: an assessment of 188 cas-es. Can Assoc Radiol J. 1994 Apr;45(2):101-7. 56. Alien R, Mendelsohn FA, Csicsmann J, Weller RF, Hurley TH, Doyle AE. A clinical evaluation of serum angiotensin con-verting enzyme in sarcoidosis. Aust N Z J Med. 1980 Oct; 10(5):496-501. 57. Khan K, Schwarzenberg SJ, Sharp H, Greenwood D, Weisdorf-Schindele S. Role of serology and routine laboratory tests in child-hood inflammatory bowel disease. Inflamm Bowel Dis. 2002 Sep; 8(5):325-9. 58. Dupuy A,Cosnes J,Revuz J,Delchier JC,Gendre JP, Cosnes A. Oral Crohn disease: Clinical characteristics and long-term follow-up of 9 cases.Arch Dermatol. 1999 Apr;135(4):439-42. 59. Rogers RS III (2000). Granulomatous cheilitis, Melkersson. Rosenthal syndrome, and orofacial granulomatosis. Arch Dermatol. 2000 Dec; 136 (12):1557-8. 60. Reed BE, Barrett AP, Katelaris C, Bilous M. Orofacial sensi-tivity reactions and the role of dietary components. Case reports. Aust Dent J. 1993 Aug;38(4):287-91. 61. Van der Waal RL, Schulten EA, Van der Meij EH, Van de Scheur MR, Starink TM, Van der Waal I. Cheilitis granulo-matosa: Overview of 13 patients with long-term follow-up-results of managementInt. J Dermatol. 2002 Apr;41(4):225-9. 62. Mignogna MD, Fedele S, Lo Russo L, Ada-mo D, Satriano RA (2004).E. Ectiveness of small-volume, intralesional, delayed-release tri-amcinolone injections in orofacial granulomato-sis:a pilot study. Int J Dermatol. 2002 Apr; 41(4):225-9. 63. Sussman GL, Yang WH, Steinberg S. Melk-ersson-Rosenthal syndrome: clinical, patholog-ic, and therapeutic considera-tions. Ann Aller-gy. 1992 Sep;69(3):187-94. 64. Hegarty A, Hodgson T, Porter S. Thalido-mide for the treat-ment of recalcitrant oral Crohn’s disease and orofacial gra-nulomatosis. Oral Surg Oral Med Oral Pathol Oral Radiol En-dod. 2003 May; 95 (5):576-85. 65. Casson DH, Eltumi M, Tomlin S, Walker-Smith JA, Murch SH. Topical tacrolimus may be e. ective in the treatment of oral and perineal Crohn ’s disease.Gut. 2000 Sep;47(3):436-40. 66. Mahadevan U, Sandborn WJ. Infliximab for the treatment of orofacial Crohn’s disease. In-flamm Bowel Dis. 2001 Feb;7(1):38-42. 67. Targan SR, Hanauer SB, Van Deventer SJ, Mayer L, Present DH, Braakman T, et al. A short-term study of chimeric monoclonal anti-body cA2 to tumor necrosis factor alpha for Crohn’s disease. Crohn’s Disease cA2 Study Group. N Engl J Med. 1997 Oct 9;337(15):1029-35. 68. Gaya DR, Aitken S, Fennell J, Satsangi J, Shand AG. Anti-TNF-alpha therapy for orofa-cial granulomatosis: Proceed with caution. Gut. 2006 Oct;55(10):1524-5. 69. Allen CM, Camisa C, Hamzeh S, Stephens L. Cheilitis granulomatosa: Report of six cases and review of the literature. J Am Acad Derma-tol. 1990 Sep;23(3 Pt 1):444-50. 70. Olivier V, Lacour JP, Castanet J, Perrin C, Ortonne JP. Cheilitis granulomatosa in a child. Arch Pediatr. 2000 Mar; 7(3):274-7. 71. Kauzman A, Quesnel-Mercier A, Lalonde B .Orofacial Granulomatosis: 2 Case Reportsand Literature Review. J Can Dent Assoc. 2006 May; 72 (4):325-9.
|